Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/94031
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia |
Autor: | Soriano, Sirena; Llorens, José V. CSIC ORCID; Blanco-Sobero, Laura; Gutiérrez, Lucía CSIC ORCID; Calap-Quintana, Pablo; Morales, M. P. CSIC ORCID ; Moltó, María D.; Martínez-Sebastián, María J. | Palabras clave: | Climbing capability Life span Oxidative stress Mitochondria Aconitase Frataxin |
Fecha de publicación: | 2013 | Editor: | Elsevier | Citación: | Gene 521(2): 274-281 (2013) | Resumen: | Friedreich's ataxia (FRDA), the most common inherited ataxia, is a neurodegenerative disease caused by a reduction in the levels of the mitochondrial protein frataxin, the function of which remains a controversial matter. Several therapeutic approaches are being developed to increase frataxin expression and reduce the intramitochondrial iron aggregates and oxidative damage found in this disease. In this study, we tested separately the response of a Drosophila RNAi model of FRDA ( Llorens et al., 2007) to treatment with the iron chelator deferiprone (DFP) and the antioxidant idebenone (IDE), which are both in clinical trials. The FRDA flies have a shortened life span and impaired motor coordination, and these phenotypes are more pronounced in oxidative stress conditions. In addition, under hyperoxia, the activity of the mitochondrial enzyme aconitase is strongly reduced in the FRDA flies. This study reports that DFP and IDE improve the life span and motor ability of frataxin-depleted flies. We show that DFP eliminates the excess of labile iron in the mitochondria and thus prevents the toxicity induced by iron accumulation. IDE treatment rescues aconitase activity in hyperoxic conditions. These results validate the use of our Drosophila model of FRDA to screen for therapeutic molecules to treat this disease. | URI: | http://hdl.handle.net/10261/94031 | DOI: | 10.1016/j.gene.2013.02.049 | Identificadores: | doi: 10.1016/j.gene.2013.02.049 issn: 0378-1119 e-issn: 1879-0038 |
Aparece en las colecciones: | (IBV) Artículos (ICMM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
37
checked on 16-mar-2024
WEB OF SCIENCETM
Citations
37
checked on 25-feb-2024
Page view(s)
311
checked on 18-mar-2024
Download(s)
120
checked on 18-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.